Good opportunity on Auro Pharma seems to be consolidating out of a correction
Hurdle 870, good for long term investors also.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.